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Summary. Cells of the macrophage lineage are a major 
source of various cytokines and hematopoietic growth 
factors. With regard to the growth factors acting on cells 
of their own lineage, macrophage colony-stimulating fac- 
tor (M-CSF) has been proven to be secreted by monocytes 
(MO) and macrophages (MAC), whereas the production 
of granulocyte-macrophage colony-stimulating factor 
(GM-CSF) by human MO/MAC is under debate. Here we 
report hat in elutriation-purified MO, as well as in MAC 
derived from cultured MO, GM-CSF m-RNA was regu- 
larly induced by LPS. In MO the GM-CSF message was 
still detectable 18h after stimulation under serum-free 
conditions, but in contrast was already lost at this time 
point in MAC. Secreted GM-CSF protein was detected in 
the culture medium using a sandwich ELISA. Further- 
more, a factor-dependent cell line (M-07) was used for a 
biological assay. Here, a neutralizing anti GM-CSF anti- 
body specifically blocked the proliferation-inducing ac- 
tivity of MO/MAC supernatants. Whereas only small 
amounts of GM-CSF were detected in MO, its secretion 
increased severalfold upon MO-to-MAC differentation i
vitro. A similar increase upon in vitro maturation of MO 
was observed for the production of granulocyte colony- 
stimulating factor. The highest amounts of GM-CSF (up 
to 2.8 rig/106 cells) were produced by MAC that had been 
derived from MO cultured under serum-free conditions 
in the presence of 0.5 rng/ml albumin as the only medi- 
um supplement. 
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Introduction 
Besides their historically well-known property of phago- 
cytosis, cells of the macrophages lineage produce a vari- 
ety of cytokines, colony-stimulating factors (CSF), and 
other secretory products. Through the secretion of these 
factors, monocytes (MO) and macrophages (MAC) are 
involved in the regulation of the function of both hema- 
topoietic and nonhematopoietic cell systems [6, 10,21]. 
The pattern of secreted proteins differs between blood 
MO and tissue MAC, as is evident from in vivo and in 
vitro studies [26, 30]. At least two of the known growth 
factors could be involved in the autocrine regulation of 
cells of the MAC lineage: macrophage-CSF (M-CSF) and 
granulocyte-macrophage-CSF (GM-CSF). M-CSF is pro- 
duced both by adherent MO and MAC [14, 18, 26]. Cur- 
rently, M-CSF is recognized to be a factor which not only 
stimulates committed progenitor cells but also acts as a 
survival and differentiation factor for MO [5, 7, 20]. GM- 
CSF, a glycoprotein of 18-23 kD [31], is a stimulator of 
stem-cell proliferation, leading to granulocyte colonies, 
granulocyte-MAC colonies, and some MAC colonies [12]. 
Similar to M-CSF, it seems to be involved in the modula- 
tion and activation of differentiated MO and MAC 
[13, 16, 24], in addition to its action on neutrophils. The 
main source of GM-CSF are activated T-cells, endothelial 
cells, and fibroblasts [10, 22, 27]. It is not clear whether 
MO and MAC are also GM-CSF-producing cells; pub- 
lished results o far are contradictory [18, 22, 27]. Here we 
report that in highly purified MO/MAC the production 
of GM-CSF is detected on the RNA and protein level, 
and that its secretion is modulated uring in vitro matu- 
ration of MO into MAC. Besides GM-CSF that acts on 
granulocytes and MO/MAC as a pluripotent growth fac- 
tor, other factors (e.g., IL-8 and granulocyte colony- 
stimulating factor, G-CSF) with major effects upon the 
granulocyte lineage are produced by MAC [4, 18,22]. 
Here we report hat the producing of G-CSF is also devel- 
opmentally regulated uring MAC differentation. 
Materials and methods 
Cell preparation 
Mononuclear cells were collected by leukapheresis of healthy 
donors and Ficoll-separation as described previously [18]. MO and 
lymphocytes (LY) were isolated by counter-current lutriation using 
a Beckmann J6-ME centrifuge with a JE 5.0 rotor and a large 
elutriation chamber (Beckmann, Munich, FRG). Elutriation was 
performed in 2070 human albumin in Hank's salt solution at con- 
stant 2500 rpm with LY being elutriated at a flow rate of 64 ml/min 
and MO at a flow rate of 110 ml/min. The monocyte fraction was 
>90070 pure, the lymphocyte fraction was >9007o pure, as deter- 
mined by the detection of CD 14, CD4, CD 8, and CD20 antigens. 
For in vitro maturation, MO were cultured at 106 cells/ml for up 
to 14 days on hydrophobic Teflon foils (Biofolie 25, Heraeus, 
Hanau, FRG) in the presence of 2070 pooled human AB-serum [1]. 
In some experiments parallel cultures were performed with 
0.5 mg/ml human albumin (Biotest, Dreieich, Germany) instead of 
serum. On the days indicated, cells were harvested from the Teflon 
bags, and washed, and viability was assessed by trypan-blue ex- 
clusion. MAC maturation was followed by morphology and the 
expression of maturation-associated ntigens [2]. 
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expressed rhu IL-3 (Sandoz, Basel, Switzerland). The M-07 cells 
were washed once in culture medium without IL-3 immediately 
before the assay. Washed cells were seeded at 2x104 per well in 
96-well plates (Falcon, Lincoln Park, N J) in the presence of either 
purified CHO-expressed rhu GM-CSF (2000 pg/ml, Sandoz, Basel, 
Switzerland), purified CHO-expressed rhulL-3 (0.3-30 ng/ml), 
serial dilutions of MO/MAC SN, or control medium containing the 
same amount of LPS as the MO/MAC SN (all in duplicates). Neu- 
tralizing anti-GM-CSF and anti-IL-3 monoclonal ntibodies were 
included at 25/zg/ml and 5/~g/ml, respectively. At these antibody 
concentrations the effect of approximately 1 ng/ml of GM-CSF or 
2 ng/ml of IL-3, respectively, was blocked. After 68 h incubation at
37~ 0.5/~Ci 3H-thymidine (15 Ci/mmol, Amersham) was added 
to each well and incubation continued for additional 4 h. Cells were 
harvested on filter papers (Inotech, Wohlen, Switzerland). After 
addition of scintillation fluid, radioactivity was determined with a 
scintillation counter (LS 3801, Beckman). Data given are cpm of 
M-07 in conditioned medium subtracted by cpm M-07 in control 
medium (the latter always below 3000 cpm). 
ELISA. Sandwich ELISA's (MRL for GM-CSF and Amgen for 
G-CSF, both distributed by Biermann, Bad Nauheim, Germany) 
were performed according to the manufacturer's protocols. 
Northern blot analysis 
Either LY, MO, or MO-derived MAC obtained after different 
culture periods were seeded into 60 mm plasic Petri dishes (Greiner, 
Solingen, Germany, or Falcon, distributed by Becton-Dickinson, 
Heidelberg, Germany) at a density of 106 cells/ml and cultured 
either with or without 100 ng/ml bacterial lipopolydsacchride from 
Salmonella bortus equii (LPS, kindly provided by C. Galanos, 
MPI, Freiburg, Germany) or phorbolmyristate acetate (PMA, 
5 x 10-I~ M) and phytohemagglutinin (PHA, 5/~g/ml). At the indi- 
cated time the supernatants (SN) were collected, filtered through 
0.22pro filters (Millipore, Bedford, MA) in order to remove cell 
debris, and stored at -20~ 
After aspiration of SN, extraction of total cellular RNA was 
performed according to Chomzynski and Sacchi [8]. Cells were 
lysed directly in the dishes with guanidium thiocyanate solution; 
6pg total RNA were dissolved in 10 pl loading buffer containing 
50070 formamide, 2.2 M formaldehyde, 20 mM MOPS, 5 mM sodium 
acetate, 1 mM EDTA, 0.04070 bromephenol b ue, 1~ Ficoll, and 
50/zg/ml ethidium bromide. Samples were run on a 1070 agarose gel 
containing 2.2M formaldehyde, 20 mM MOPS, 5 mM sodium ace- 
tate, 1 mM EDTA, without ethidium bromide, and transferred to 
nylon membranes (Nytran, Schleicher& Schuell, Dassel, Germany) 
by capillary blotting in 20x SSC. The ethidium bromide-stained 
RNA was visualized on the wet filters by transillumination with UV 
light and photographed to verify that all lanes contained equal 
amounts of RNA. GM-CSF mRNA was detected by hybridization 
with a cDNA probe (kindly provided by D. Krumwieh, Behring- 
werke, Marburg, Germany) labeled with [3zP 1 dCTP (3000 Ci/mmol, 
Amersham, Buckinghamshire, England) by the random prime 
method with a commercially avaiable kit (Amersham). Hybridiza- 
tion conditions were 500mM sodium phosphate pH 7.2, 7% SDS, 
1 mM EDTA, 150 r tRNA (adapted from Church and Gilbert 
[9]) at 65~ over night. Washing conditions were 0.1xSSC, 1070 
SDS at 52~ (three times for 30 min). 
Quantitation of GM-CSF and G-CSF in cell culture supernatants 
Biological assay Supernatants of MO/MAC were tested for GM- 
CSF and Interleukin-3 (IL-3) using the leukemia cell line M-07 [3]. 
These cells depend on GM-CSF and/or IL-3 for cell growth. Cell 
were maintained inDMEM supplemented with 100 U/ml penicillin, 
100 pg/ml streptomycin, 2 mM L-glutamine, 13/~g/1 ct-thioglycerol 
(all from Gibco, Paisley, Scotland), 10070 heat-inactivated fetal 
bovine serum (Boehringer, Mannheim, FRG), and 10 U/ml CHO- 
Results 
At first we tested cell culture supernatants by a bioassay 
with the growth factor-dependent cell line M-07. Super- 
natants of LPS-stimulated MO and MAC induce the 
growth of M-07 cells. Bioactivity in the SN was blocked 
by the addit ion of an ant i -GM-CSF antibody, but only to 
minimal  degrees by the addit ion of an anti IL-3 antibody, 
indicating that MO and MAC secrete biologically active 
GM-CSF upon st imulation with LPS. A typical experi- 
ment is shown in Fig. 1. On comparison of the activity of 
the MAC-condit ioned media with serial dilutions of re- 
combinant GM-CSF, the bioactivity in the SN correspond- 
ed to 1.1 ng/ml  recombinant GM-CSF. In several other 
3H Thymidine uptake (cpm) 
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Fig. 1. Growth promotion of factor-dependent M-07 cells by MAC 
supernatants and its inhibition by anti-GM-CSF antibodies. Serial 
dilutions of conditioned media of LPS-stimulated, MO-derived 
MAC were incubated with M-07 cells, either alone (control), with 
neutralizing anti-IL-3 antibody (MAb), or with neutralizing anti- 
GM-CSF antibody 
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experiments GM-CSF bioactivity in the range of 
3.0-1.1 ng/ml was detected. No GM-CSF bioactivity was 
found in the conditioned media of unstimulated MO or 
MAC. 
In addition to the findings in the bioassay, we detected 
and quantitated GM-CSF protein by sandwich ELISA. In 
preliminary experiments, not shown in detail here, MO 
and MAC constantly produced higher amounts of GM- 
CSF when stimulated with LPS under serum-free culture 
conditions. This is in contrast o other factors such as 
TNF, IL-1, and G-CSF that are produced in higher 
amounts in the presence of serum. Therefore, for meas- 
urements of GM-CSF, stimulation of MO/MAC was car- 
ried out in the absence of serum, unless indicated other- 
wise. The amount of G-CSF was determined in parallel 
cultures that had been stimulated in the presence of 2% 
human serum. Neither G-CSF nor GM-CSF was detected 
in unstimulated MO/MAC cultures. During in vitro 
maturation of MO into MAC the amount of GM-CSF 
secretion increased severalfold. The time course, as well 
as the extent to which GM-CSF production was up- 
regulated uring MO-to-MAC maturation, differed in 
individual experiments. The results of two representative 
experiments are shown (Fig. 2). The capability of mature 
MAC to secrete higher amounts of GM-CSF compared 
with freshly isolated MO was confirmed with cells of 
several different donors. While stimulated MO produced 
up to 100 pg/ml GM-CSF (in some experiments below the 
detection threshold of 10pg/ml), GM-CSF was secreted 
in the range of 200-700pg/ml by MAC that had been 
allowed to mature for 8-14 days (the GM-CSF values 
determined by ELISA tended to be slightly lower than the 
values determined by bioassay with the M-07 cell line; not 
shown in detail). 
The secretion of G-CSF increased to a similar extent 
as did the secretion of GM-CSF during MO-to-MAC ma- 
turation. We detected up to 0.3 ng/ml G-CSF in MO SN 
and up to 5 ng/ml G-CSF in MAC SN. As for GM-CSF, 
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Fig. 2 a -  d. Influence of MO-to-MAC differentiation on stimulated GM-CSF and G-CSF secretion. Purified MO were either used directly 
or cultured in Teflon bags. After the indicated period of time, cells were detached from the Teflon bags, seeded into plastic dishes at 106 cells/ml, 
and incubated with LPS for 24 h in serum-free medium for the measurement of GM-CSF, or in the presence of 2% human serum for the 
detection of G-CSF. Conditioned media were tested for GM-CSF and G-CSF by ELISA. Two independent experiments are shown (Exp 
1 and Exp 2) 
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Fig. 3 a, b. Detection of GM-CSF mRNA in purified lympho- 
cytes and monocytes. LY and MO were elutriated from the 
same batch of mononuclear cells. Total RNA was extracted 
4 h after stimulation with either LPS or PMA and PHA, 
respectively, a Detection of GM-CSF RNA; b ethidium 
bromide staining. Lane 1." LY, unstimulated; lane 2: LY, stimu- 
lated with PMA and PHA; lane 3: LY, stimulated with LPS; 
lane 4: MO, unstimulated; lane 5: MO, stimulated with LPS 
the time course of the increase in G-CSF production 
during the maturation process varied between different 
experiments (Fig. 2). 
To further support our findings we performed noth- 
ern blots and hybridization with a GM-CSF-specific pro- 
be. In LY, only upon stimulation with PMA and PHA 
but not upon stimulation with LPS was the typical GM- 
CSF signal at about 1.1 kb detected, whereas LPS induc- 
ed the GM-CSF message in purified MO of the same 
donor (Fig. 3). For neither of the cell populations was 
GM-CSF mRNA detected without previous stimulation. 
In an indepent experiment after stimulation with LPS a 
higher level of  GM-CSF mRNA was detected in purified 
MO than in a mixed population of mononuclear cells 
(data not shown in detail). These observations rule out 
the possibility of contaminating LY as the source of 
GM-CSF in MO. 
9 Our next goal was to determine the time course of the 
GM-CSF mRNA induction in MO and MAC. RNA was 
extracted 2, 6, and 18 h after stimulation with LPS either 
in the presence or in the absence of human serum. GM- 
CSF mRNA appeared later in MO than in MAC but per- 
sisted longer (Fig. 4). In MO, the GM-CSF message was 
detected caller and disappeared earlier when the cells 
were stimulated in the presence of serum. In three similar 
time-course experiments, elevated GM-CSF mRNA levels 
were detected under serum-flee conditions in MO at the 
18 h time point; however, in two of the experiments a 
strong signal was already observed in these cells at the 6 h 
time point. In MAC no difference in the time kinetics of 
GM-CSF mRNA was observed in the presence or absence 
of serum. 
Finally, we wanted to determine whether the GM-CSF 
production of MAC was modulated by the culture condi- 
tions during the in vitro maturation process. Serum- 
induced MAC are phenotypically and functionally diffe- 
rent from cells cultivated serum free with human serum 
albumin as the only medium supplement, i. e., the latter 
survive at a lower percentage, produce less TNF, and ex- 
press maturation-associated antigens at a lower density 
[17]. In the majority of experiments, MAC obtained from 
Fig. 4a, b. Time course of GM-CSF message in MO and MO- 
derived MAC. MO and MO-derived MAC (7 days old) derived from 
a single leukapheresis product were stimulated with LPS either in 
serum-free culture medium (lanes 1, 3, 5, 7, 9, H) or in the presence 
of 2~ human serum (lanes 2, 4, 6, 8, 10, 12). RNA was extracted 
2, 6, and 18h after stimulation, a GM-CSF RNA; b ethidium 
bromide staining 
albumin cultures showed a higher GM-CSF mRNA level 
and secreted larger quantities of GM-CSF into the cul- 
ture medium than MAC obtained from serum cultures 
(Fig. 5). 
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Fig. 5 a, b. Induction of GM-CSF in MAC obtained from MO grown under dif- 
ferent culture conditions. MO were grown in the presence of 2% human serum 
(lanes 1 and2) or in the presence of 0.5 mg/ml human serum albumin as theonly 
medium supplement (lanes 3 and 4). After 7 days, ceils were harvested and 
cultured in plastic dishes ata density of 106/ml with or without LPS. a RNA was 
extracted after 4 h and probed for GM-CSE SN of parallel cultures were harvested 
after 24 h for determination ofGM-CSF contents by ELISA. b Ethidium bromide 
staining. 
Discussion 
In several indepedent experiments he production of GM- 
CSF by LPS-stimulated MO and MAC was a consistent 
finding. Our results support he findings made by other 
groups [18, 27] and it is likely that MO/MAC can produce 
this factor also in vivo. Most importantly, the GM-CSF 
production of mononuclear phagocytes depends upon 
their state of differentiation. The increase in the produc- 
tion of GM-CSF during MO-to-MAC maturation cor- 
relates with the increased capacity of mature MAC to 
secrete M-CSF, TNF, and neopterin, whereas other fac- 
tors (e. g., IL-1) are down-regulated [26, 30]. As we show 
here, G-CSF production rises in a similar fashion during 
this maturation process. On the mRNA level there is no 
clearly visible difference in GM-CSF content between 
MO and MAC, probably because MAC contain about 
five times the amount of total RNA compared with MO; 
however, on a per-cell level the production of GM-CSF 
protein by mature MAC is reproducibly several times 
higher than that by blood MO. This massive increase in 
GM-CSF secretion had led us to earlier findings [251; we 
detected GM-CSF only in the SN of MAC and not in that 
of blood MO due to the less sensitive detection methods 
avaiable at that time. Other groups who did not detect 
GM-CSF when experimenting whith freshly isolated MO 
might have dealt with the same problem. 
The increase of GM-CSF secretion in MAC is accom- 
panied by the faster induction of GM-CSF mRNA in 
MAC: more GM-CSF is produced in a shorter period of 
time, but the down-regulation of GM-CSF mRNA occurs 
faster that in MO, too. Both the slower increase and the 
decrease of the GM-CSF message in MO are accelerated 
in the presence of serum. In MAC, the GM-CSF mRNA 
response is already faster than in MO and cannot be 
further accelerated by serum. Therefore, in terms of the 
GM-CSF mRNA kinetics, the presence of serum as a fast 
modulatory effect partially mimics the slow process of 
MO-to-MAC differentation. Whether this similar effect 
is achieved by similar intracellular mechanims affecting 
mRNA production and/or stability remains to be clari- 
fied. However, only the time course of GM-CSF expres- 
sion in MO is shifted to a MAC-like pattern in the presen- 
ce of serum, whereas the cumulated secretion of GM- 
CSF tends to decrease as compared with serum-free con- 
ditions. In contrast o the results of Thorens et al. [28], 
who performed their experiments with mouse macro- 
phages cultured in fetal calf serum, we never found an in- 
duction of GM-CSF in the presence of serum alone. 
At the present ime we have no explanation for the 
high GM-CSF levels produced by MAC derived from 
albumin-containing cultures. As we used pyrogen-free 
clinical-grade albumin, contaminating endotoxin or other 
pyrogens in the Teflon cultures can be ruled out. How- 
ever, priming events through denatured compounds that 
are not present in total serum are still possible. Neverthe- 
less, it is temping to speculate that cells kept under sub- 
optimal culture conditions are more easily stimulated to 
produce GM-CSF as a growth factor of their own lineage; 
in this picture, missing signals instead of positive signals 
would lead to the priming event. The modulation of re- 
sponsiveness by the cultivation of MO under different 
culture conditions is an interesting model system, useful 
for studying the influence of microenvironmental signals 
during MAC maturation in vivo [11, 17]. Attempts to 
characterize such modulatory factors in detail are under 
way. 
By the secretion of GM-CSF, MO and MAC can help 
to induce the production of cells of their own lineage as 
well as the production of granulocytes. In addition to its 
function of cell recruitment, MAC-activating properties 
of GM-CSF [13, 15,24] are well documented. Further- 
more, GM-CSF leads to enhanced accessory function for 
T-cell activation in MAC [16,231, and it is an important 
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survival factor for circulating dendrit ic cells [19]. Via the 
secretion of  GM-CSF, MAC not only effect hematopoiesis 
but also induce the funct ional  activity of  mature granulo- 
cytes in a concerted action with other monokines like 
IL-8 [4]. I f  the developmental  regulat ion of  these factors 
observed in vitro also occurs in vivo, interaction of  mono-  
nuclear phagocytes with other leukocytes might be simi- 
lar ly potent iated when b lood MO migrate into inf lamed 
tissues and transform into reactive MAC.  
In conclusion, our results prove that GM-CSF  is a 
constituent of  the secretory repertoire of  human MAC.  
Thus, st imulated by bacterial  endotoxins and probably  
other factors, and acting synergistically with such factors 
as G-CSF  and IL-8, the product ion of  GM-CSF  by MO 
and MAC might st imulate the in f lammatory  infi ltrate 
and play a role in the further recruitment of mononuc lear  
phagocytes and other cells involved in the pathogenesis of
acute and chronic in f lammat ion.  
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